Cargando…
Pathogen-Specific Clinical Trials: A New Paradigm in Clinical Trials for Multidrug-Resistant Organisms
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Healthcare
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6249180/ https://www.ncbi.nlm.nih.gov/pubmed/30284146 http://dx.doi.org/10.1007/s40121-018-0215-0 |
| _version_ | 1783372686802550784 |
|---|---|
| author | Jorgensen, Sarah C. J. Rybak, Michael J. |
| author_facet | Jorgensen, Sarah C. J. Rybak, Michael J. |
| author_sort | Jorgensen, Sarah C. J. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6249180 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | Springer Healthcare |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-62491802018-12-06 Pathogen-Specific Clinical Trials: A New Paradigm in Clinical Trials for Multidrug-Resistant Organisms Jorgensen, Sarah C. J. Rybak, Michael J. Infect Dis Ther Editorial Springer Healthcare 2018-10-03 2018-12 /pmc/articles/PMC6249180/ /pubmed/30284146 http://dx.doi.org/10.1007/s40121-018-0215-0 Text en © The Author(s) 2018 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
| spellingShingle | Editorial Jorgensen, Sarah C. J. Rybak, Michael J. Pathogen-Specific Clinical Trials: A New Paradigm in Clinical Trials for Multidrug-Resistant Organisms |
| title | Pathogen-Specific Clinical Trials: A New Paradigm in Clinical Trials for Multidrug-Resistant Organisms |
| title_full | Pathogen-Specific Clinical Trials: A New Paradigm in Clinical Trials for Multidrug-Resistant Organisms |
| title_fullStr | Pathogen-Specific Clinical Trials: A New Paradigm in Clinical Trials for Multidrug-Resistant Organisms |
| title_full_unstemmed | Pathogen-Specific Clinical Trials: A New Paradigm in Clinical Trials for Multidrug-Resistant Organisms |
| title_short | Pathogen-Specific Clinical Trials: A New Paradigm in Clinical Trials for Multidrug-Resistant Organisms |
| title_sort | pathogen-specific clinical trials: a new paradigm in clinical trials for multidrug-resistant organisms |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6249180/ https://www.ncbi.nlm.nih.gov/pubmed/30284146 http://dx.doi.org/10.1007/s40121-018-0215-0 |
| work_keys_str_mv | AT jorgensensarahcj pathogenspecificclinicaltrialsanewparadigminclinicaltrialsformultidrugresistantorganisms AT rybakmichaelj pathogenspecificclinicaltrialsanewparadigminclinicaltrialsformultidrugresistantorganisms |